Trexquant Investment’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $617K | Sell |
89,285
-115,206
| -56% | -$888K | ﹤0.01% | 1403 |
|
|
2025
Q4 | $1.8M | Buy |
+204,491
| New | +$1.13M | 0.02% | 1027 |
|
|
2025
Q2 | – | Sell |
-192,110
| Closed | -$882K | – | 1912 |
|
|
2025
Q1 | $882K | Sell |
192,110
-34,566
| -15% | -$161K | 0.01% | 1127 |
|
|
2024
Q4 | $1.09M | Buy |
226,676
+22,229
| +11% | +$107K | 0.01% | 1081 |
|
|
2024
Q3 | $959K | Buy |
204,447
+132,613
| +185% | +$711K | 0.01% | 1064 |
|
|
2024
Q2 | $406K | Buy |
+71,834
| New | +$371K | 0.01% | 1300 |
|
|
2024
Q1 | – | Sell |
-104,511
| Closed | -$441K | – | 1817 |
|
|
2023
Q4 | $441K | Sell |
104,511
-169,741
| -62% | -$685K | 0.01% | 1122 |
|
|
2023
Q3 | $1.18M | Buy |
274,252
+262,088
| +2,155% | +$1.46M | 0.03% | 684 |
|
|
2023
Q2 | $80.2K | Sell |
12,164
-37,293
| -75% | -$239K | ﹤0.01% | 1378 |
|
|
2023
Q1 | $336K | Sell |
49,457
-12,285
| -20% | -$86.4K | 0.01% | 1155 |
|
|
2022
Q4 | $456K | Buy |
61,742
+29,820
| +93% | +$290K | 0.01% | 952 |
|
|
2022
Q3 | $315K | Buy |
31,922
+2,948
| +10% | +$31.1K | 0.01% | 1009 |
|
|
2022
Q2 | $316K | Sell |
28,974
-41,203
| -59% | -$427K | 0.01% | 1089 |
|
|
2022
Q1 | $794K | Buy |
70,177
+41,254
| +143% | +$542K | 0.04% | 569 |
|
|
2021
Q4 | $454K | Buy |
+28,923
| New | +$504K | 0.03% | 698 |
|
|
2021
Q2 | – | Sell |
-15,393
| Closed | -$231K | – | 1532 |
|
|
2021
Q1 | $231K | Buy |
15,393
+575
| +4% | +$9.31K | 0.02% | 902 |
|
|
2020
Q4 | $195K | Sell |
14,818
-38,911
| -72% | -$468K | 0.02% | 891 |
|
|
2020
Q3 | $519K | Buy |
53,729
+3,267
| +6% | +$34.9K | 0.03% | 664 |
|
|
2020
Q2 | $577K | Buy |
+50,462
| New | +$571K | 0.04% | 618 |
|
|
2019
Q4 | – | Sell |
-29,800
| Closed | -$396K | – | 1287 |
|
|
2019
Q3 | $396K | Buy |
29,800
+8,608
| +41% | +$120K | 0.03% | 528 |
|
|
2019
Q2 | $299K | Buy |
+21,192
| New | +$337K | 0.03% | 603 |
|
|
2018
Q4 | – | Sell |
-22,837
| Closed | -$524K | – | 1326 |
|
|
2018
Q3 | $524K | Buy |
22,837
+11,683
| +105% | +$239K | 0.04% | 521 |
|
|
2018
Q2 | $212K | Buy |
+11,154
| New | +$187K | 0.01% | 776 |
|
|
2017
Q3 | – | Sell |
-23,568
| Closed | -$384K | – | 1048 |
|
|
2017
Q2 | $384K | Buy |
+23,568
| New | +$340K | 0.11% | 347 |
|
|
2016
Q4 | – | Sell |
-11,100
| Closed | -$185K | – | 1147 |
|
|
2016
Q3 | $185K | Buy |
+11,100
| New | +$149K | 0.04% | 651 |
|
|
2016
Q1 | – | Sell |
-57,005
| Closed | -$531K | – | 1199 |
|
|
2015
Q4 | $531K | Buy |
+57,005
| New | +$569K | 0.05% | 658 |
|
|
2015
Q2 | – | Sell |
-78,400
| Closed | -$729K | – | 1258 |
|
|
2015
Q1 | $729K | Buy |
+78,400
| New | +$886K | 0.07% | 520 |
|
Other funds holding VNDA
ACM
VCM
